新和成(002001) - 2018 Q2 - 季度业绩预告

Financial Performance Forecast - The company expects a net profit attributable to shareholders for the first half of 2018 to be between 2,021.51 million yuan and 2,197.29 million yuan, a decrease of 245% to 275% compared to the same period last year[3]. - The previous forecast estimated a net profit of 2,226.59 million yuan to 2,519.56 million yuan for the same period[3]. - The net profit for the same period last year was 585.94 million yuan[3]. Reasons for Decline - The decline in net profit is attributed to a decrease in the sales price of vitamin E and a reduction in product gross margin[5]. Audit and Finalization - The performance forecast revision has not been audited by registered accountants[4]. - The financial data provided is preliminary and will be finalized in the company's 2018 semi-annual report[6]. Apology to Investors - The company has expressed sincere apologies for any inconvenience caused to investors due to the performance forecast revision[7].